6th Annual Community Oncology Conference

February 25-26, 2011

 

Abstracts

Call for Abstracts/Poster Presentations

Authors interested in presenting scientific data on the supportive and palliative care of patients with cancer should submit an abstract for review. Abstracts of superior quality will be selected by the scientific program committee for a poster presentation at the Seventh Annual Chicago Supportive Oncology Conference (October 27–29, 2011) and will be published in The Journal of Supportive Oncology. Abstracts will also be available for viewing online at www.SupportiveOncology.net.

Abstract Deadline
The deadline for submission of an abstract is August 15, 2011. Please note that this deadline is final, and we can offer no special consideration to submissions received after this date; abstracts received after the deadline will not be reviewed.

Submission Method
All abstracts must be submitted via electronic mail, as a Word document attachment. Abstracts should be sent to the attention of Susan Hite, at susan.hite@elsevier.com. Submissions must also be accompanied by an Abstract Submission Form and a Faculty Disclosure Form   .

Confirmation of Submission
Presenters will be notified by e-mail upon receipt of all parts of the submission, including (1) the abstract, (2) the Abstract Submission Form, and (3) the Faculty Disclosure Form.

Notification
Notification regarding acceptance or rejection of abstracts will be made by e-mail in mid-August 2011. At that time, further details about the conference schedule and poster specifications will be provided to the presenting author. If you have not received an e-mail notification by August 16, 2011, please contact Susan Hite at susan.hite@elsevier.com or call 240-221-2471.

Abstract Guidelines
Read these guidelines carefully before sending the abstract.

  • All abstracts must be submitted via e-mail, as a Word document attachment.
  • All abstracts will be peer reviewed. Acceptance will be based on originality and importance to the field of supportive oncology. The decision of the scientific committee in this regard will be final.
  • When submitting an abstract for consideration, please include the following:
    1. Title: The abstract title should be brief and reflect the contents of the abstract.
    2. Authors: List all authors by last name followed by initials of first and middle names. Please indicate the presenting author's name. All correspondence will be with the presenting author.
    3. Affiliations: Please group institutions together and provide institution names, cities, state/provinces, and country of origin if not the United States.
    4. Content: Abstracts should be organized according to four sections: Background, Methods, Results, Discussion. Abstracts may include one data table, but illustrations and figures are not permitted. Abstracts may not be longer than 250 words.
  • Abstracts will be judged solely on the data submitted. Promises that "further data will be provided" are discouraged and will decrease the likelihood of the abstract's acceptance.
  • Data from long-term clinical trials may be represented if there is significant new information to add.
  • Only standard abbreviations should be used, and they should be kept to a minimum.
  • Use generic names for drugs.

Submission Conditions
Read these conditions carefully before sending the abstract.

  • All submitters who are accepted for poster presentations must register and pay conference registration fees. Only abstracts by authors who have paid their registration fees as of August 16, 2011 will be scheduled for presentation and included in the conference materials.
  • There are no limits to the number of abstracts an individual may author.
  • Accepted abstracts will be on display throughout the conference during exhibit hall hours. A General Poster Session/Reception will be held on the evening of Thursday, October 27, 2011, from 5:00 to 6:30 pm. Presenting authors should be available at their poster during this evening reception to answer questions from meeting attendees.
  • Submission of the abstracts automatically grants the organizers permission to publish them in The Journal of Supportive Oncology and on the Web at www.SupportiveOncology.net.
  • Abstracts accepted for presentation will be published exactly as submitted and should be checked for accuracy and misspelling prior to submission.
  • Requests for withdrawal of a poster must be made in writing before August 16, 2011.

CSOC Young Investigator Awards
The purpose of the CSOC (Chicago Supportive Oncology Conference) Young Investigator Award is to recognize the professional development of scientists-in-training who are pursuing research in the field of supportive oncology. Awards for outstanding abstracts submitted and accepted by young investigators will be announced at the meeting. To be considered a Young Investigator, an author must meet the following criteria:

  • Must be 40 years or younger as of the start of the meeting (October 27, 2011)
  • Must have received a graduate degree (MD, PhD, MSN, PA, MPH, MSc, PharmD, etc.)
  • Must have fewer than 5 years of research experience at the start of the meeting.

Industry-Supported Abstracts Only
The fee for submitting an industry-supported abstract is $200 (per abstract).